col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


56 Ergebisse       Seite 1

 [1] 
Oxford University Press: Medical Mycology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―08 KL-6 as a Predictor of Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis (CAPA) and Mortality in Critically Ill Covid-19 Patients: A Single-Center Retrospective Cohort Study Hyun Kyu Cho, Si-Ho Kim, Cheon-Hoo Jeon, Jae Wan Jung, Yu Mi Wi
2 [GO] 2025―Mrz―06 COVID-19-associated invasive fungal infections in intensive care unit patients during the first pandemic waves in Argentina: Results of a single center experience Gladys Beatriz Posse, Fernanda Mariel Barberis, María Fernanda Benedetti, Daniel Pezzola, Katherine Hermida Alava, Carolina Rodríguez Laboccetta, et al. (+5)
3 [GO] 2025―Mrz―06 COVID-19 Associated Pulmonary Aspergillosis in a Tertiary Care Center in the Midwestern Region of Brazil CAPA in a Hospital in Brazil Marina Miranda Ely, Andyane Freitas Tetila, Anamaria Mello Miranda Paniago, Luana Rossato
4 [GO] 2025―Jan―14 The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units Emre Kara, Gokhan Metan, Dolunay Gülmez, Sevtap Arikan-Akdagli
5 [GO] 2024―Jun―23 Factors Influencing Mortality in COVID-19-Associated Mucormycosis - The International ID-IRI Study Meyha Sahin, Mesut Yilmaz, Ali Mert, Behrouz Naghili, Fatemeh Ravanbakhsh, Mojtaba Varshochi, et al. (+28)
6 [GO] 2024―Apr―08 Comparison of Candida colonization in intensive care unit patients with and without COVID-19: First prospective cohort study from Turkey Ilvana Çaklovica Küçükkaya, Günseli Orhun, Arif Atahan Çağatay, Sadık Kalaycı, Figen Esen, Fikrettin Şahin, et al. (+2)
7 [GO] 2024―Mrz―28 Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics Rebecca van Grootveld, Judith van Paassen, Eric C J Claas, Laura Heerdink, Ed J Kuijper, Mark G J de Boer, Martha T van der Beek
8 [GO] 2024―Mrz―13 Revealing the hidden interplay: the unexplored relationship between fungi and viruses beyond HIV, SARS-CoV-2 and influenza Théo Ghelfenstein-Ferreira, Alexandra Serris, Maud Salmona, Fanny Lanternier, Alexandre Alanio
9 [GO] 2023―Dez―22 Predicting Intracranial Involvement: Unveiling Perineural Spread in COVID-19-Associated Mucormycosis, a Novel Phenomenon Nidhin Das K, Vidhu Sharma, Diksha Gupta, Sarbesh Tiwari, Poonam Elhence, Vidhi Jain, et al. (+2)
10 [GO] 2023―Sep―13 Diagnosis of mucormycosis using a simple duplex PCR assay: analysis of 160 clinical samples from COVID-19 patients Shima Aboutalebian, Mahzad Erami, Amir Hossein Ahsaniarani, Mansooreh Momen-Heravi, Alireza Sharif, Mahboubeh Hadipour, Hossein Mirhendi
11 [GO] 2023―Aug―22 Percentage of Th1 and Th17 Cells and Serum Level of IL-17 and IFN-γ cytokines in COVID-19-associated Mucormycosis Narjes Soleimanifar, Sara Assadiasl, Abdolrahman Rostamian, Alireza Abdollahi, Mohammadreza Salehi, Mohsen Abdolmaleki, et al. (+6)
12 [GO] 2023―Jul―14 Yeasts from blood cultures in the wake of the COVID-19 pandemic in a tertiary care hospital: Shift in species epidemiology, steady low antifungal resistance and full in vitro ibrexafungerp activity Judith Díaz-García, Aina Mesquida, Marina Machado, Carlos Sánchez-Carrillo, Patricia Muñoz, Pilar Escribano, Jesús Guinea
13 [GO] 2023―Jun―08 Evidence of anti-Hcp100 antibodies in COVID-19 critically ill patients with detectable anti-histoplasmin antibodies in a highly endemic area for histoplasmosis María A Toscanini, Fernanda Barberis, Fernanda Benedetti, Carolina Rodríguez Laboccetta, Agustín Videla Garrido, Víctor Fernández Briceño, et al. (+4)
14 [GO] 2023―Jun―08 Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study Rahul Costa-Pinto, Sarah Klink, Hannah Rotherham, Padeepa Perera, Liam Finlay, Karen Urbancic, et al. (+3)
15 [GO] 2023―Mrz―12 Microbial and clinical epidemiology of invasive fungal rhinosinusitis in hospitalized COVID-19 patients, the divergent causative agents Mahzad Erami, Shima Aboutalebian, Seyed Jamal Hashemi Hezaveh, Roshanak Daie Ghazvini, Mansooreh Momen-Heravi, Yazdan Jafari, et al. (+4)
16 [GO] 2022―Dez―08 Can bronchial secretion cultures identify the etiologic agent of COVID-19-associated pulmonary aspergillosis in ICU patients? Comparison with a species-specific Aspergillus PCR in serum Maria Siopi, Stavroula Antonopoulou, Paraskevi Mantzana, Panagiota-Christina Georgiou, Sophia Vourli, Efthymia Protonotariou, et al. (+4)
17 [GO] 2022―Sep―20 P313 A retrospective analysis of COVID-19 - associated Mucormycosis in a tertiary care center in Northern India Sukriti Yadav, Ishani Bora, Gursimran Kaur Mohi, M R Shivaprakash, Mini P Singh, R K Ratho, Manjul Muralidharan
18 [GO] 2022―Sep―20 P155 A Mexican case series of COVID-19 - associated pulmonary aspergillosis Diana Perales-Martinez, Jesus Ruiz-Quiñones, Corazón de Jesús Barrientos-Flores, Daniel Aguilar-zapata
19 [GO] 2022―Sep―20 P182 Mucormycosis in Northwest Iranian cases with a history of delta COVID-19, a brief report Kambiz Diba, Reza Samarei, Rahim Nejadrahim, Atefeh Namaki
20 [GO] 2022―Sep―20 P189 The effect of COVID-19 and immunosuppressive drugs and diabetes on the spread of mucomycosis Maryam Esfidani
21 [GO] 2022―Sep―20 P184 Candida auris candidemia in COVID-19 and post-COVID-19 patients in a tertiary care hospital in North India Ajai Kumar Dixit, Rungmei S. K. Marak, Chitra Bhartiya, Afzal Azim, Chinmoy Sahu, Shikha Tripathi
22 [GO] 2022―Sep―20 P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis Rajeev Soman, Sourabh Chakraborty, Geethu Joe, Bharat Purandare, Rasika Joshi, Sampada Patwardhan
23 [GO] 2022―Sep―20 P170 Life threatening hemoptysis in COVID-19 associated Pulmonary Aspergillosis (CAPA) Rajeev Soman, Sourabh Chakraborty, Vineet Rao, Shailesh Rohit, Geethu Joe
24 [GO] 2022―Sep―20 P183 Monitoring of candida colonization in the respiratory tract of COVID-19 cases Kambiz Diba, Khadige Makhdoomi, Rahim Nejadrahim, Atefeh Namaki
25 [GO] 2022―Sep―20 P442 Bacterial and fungal infection in COVID-19 diagnosed cases in a tertiary care ICU setting in the wake of second wave in Kolkata, India Soumyadeep Seal, Dip Narayan Mukherjee
26 [GO] 2022―Sep―20 P211 Fungal and bacterial co-infections of the respiratory tract among patients with COVID-19 hospitalized in intensive care units Hasti Kamali Sarvestani, Mahmoud Khansari, Zahra Rafat, Alireza Abdollahi
27 [GO] 2022―Sep―20 P334 Fungal infections in patients with COVID-19 in 1-year pandemic 2020-2021 from Cote d'Ivoire David Koffi, Andre Toure, Valerie Ira, M. Francis Kouadjo, Reine M'boh, Karidia Sylla, Mireille Dosso
28 [GO] 2022―Sep―20 P156 Oral Candidiasis among inpatients with COVID-19 in the North of Iran Fatemeh Ahangarkani, Farhang Babamahmoodi, Mohammad Sadegh Rezai, Ali Mohammadi-Kali, Narges Najafi, Reza Alizadeh-Navaei, Hamid Badali
29 [GO] 2022―Sep―20 P135 Immunological correlation with clinicomycological aspects of fungal rhinosinusitis during COVID-19 pandemic Mohan Vashistha
30 [GO] 2022―Sep―20 P262 Clinico- microbiological profile of post-COVID pulmonary fungal infections encountered during the second wave of COVID-19 pandemic at a tertiary care teaching hospital in the Himalayas Oshin Puri, Mohit Bhatia, U Sasi Rekha, Deepika Chakraborty, Ruchi Dua, Minakshi Dhar, et al. (+4)
31 [GO] 2022―Sep―20 P159 The impact of COVID-19 pandemic on invasive Candida auris infections in Kuwait Faten Al-Wathiqi, Alaa Alabdallah, Khaled Alobaid
32 [GO] 2022―Sep―20 P430 Correlation of microscopy and culture findings with serum ferritin level for the diagnosis of rhino-orbito-cerebral Mucormycosis during COVID-19 pandemic-a study from tertiary care hospital India Jothisri Lakshmanan, Shukla Das, Narendra Pal Singh
33 [GO] 2022―Sep―20 P263 Invasive Pulmonary Aspergillosis (IPA) Among Non-Intubated COVID-19 Patients-a New Age Fungal Storm Raghapriya Raghu, Jayanthi Savio
34 [GO] 2022―Sep―20 S1.1d Risk factors associated with oropharyngeal candidiasis in COVID-19 patients: a case control study Mohammadreza Salehi, Reyhaneh Sadat Kiyaei, Sadegh Khodavaisy, Nasim Khajavirad, Seyed Ali Dehghan Manshadi, Ilad Alavi Darazam, Arash Seifi
35 [GO] 2022―Sep―20 P282 Bacterial co-infections in Mucormycosis infected COVID-19 patients: experience from a tertiary care center in India Neha Sharad, Smriti Srivastava, Aparna Ningombam, Vandana Kiro, Sharin Varma, Sharad Srivastav, et al. (+2)
36 [GO] 2022―Sep―20 P291 Aspergillosis: another force to reckon with during COVID-19 times Nidhi Singla, Surinder Singhal, Deepak Aggarwal, Varinder Saini, Varsha Gupta
37 [GO] 2022―Sep―20 P365 Upsurge of Mucormycosis in COVID-19-a retrospective study in a tertiary care hospital in Punjab Sangeetha Mohan
38 [GO] 2022―Sep―20 P233 COVID-19-a ssociated Mucormycosis: an experience of invasive fungal sinusitis from a tertiary care referral center in Northern India Rungmei S K Marak, Radhika Chaudhary, Amit Kumar Keshri, Surendra Singh Baghel, Ravi Sankar Manogaran, Ajai Kumar Dixit, Prabhakar Mishra
39 [GO] 2022―Sep―20 P163 Successful management of COVID-19-associated mucormycosis in state of pernambuco, northestearn brazil: 2 case reports Filipe Batista, Eduardo Araújo, Daniela Takano, Claudia Ferraz, Carolina Guerra, Tiago Ferraz, et al. (+3)
40 [GO] 2022―Sep―20 P338 Clinicopathologic analysis of COVID-19-associated mucormycosis-experience from a tertiary care center in north india Arupparna Sengupta, Sunayana Misra, Shashi Dhawan, Sonia Badwal
41 [GO] 2022―Sep―20 P446 Molecular detection of fungal agents responsible for COVID-19-associated mycosis directly from tissue specimens Vikramjeet Singh, Anupam Das, Ashish Chandra Agarwal, Nikhil Gupta, Manodeep Sen, Jyotsna Agarwal
42 [GO] 2022―Sep―20 P424 Comparative analysis of Galactomannan Lateral Flow Assay, Galactomannan Enzyme Immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis Mohammad Hedayati, Mona Ghazanfari, Jamshid Yazdani Charati, Lotfollah Davoodi, Amir Arastehfar, Maryam Moazeni, et al. (+5)
43 [GO] 2022―Sep―20 S3.3d Influenza versus COVID-19-associated pulmonary aspergillosis: Profiling lower respiratory tract epithelial and myeloid innate immunity in patient samples Simon Feys, Samuel M. Gonçalves, Mona Khan, Sumin Choi, Bram Boeckx, Denis Chatelain, et al. (+28)
44 [GO] 2022―Sep―20 P398 COVID-19-associated pulmonary aspergillosis: Species distribution and susceptibility profiles Hamed Fakhim, Afsane vaezi, Elahe nasri, Somayeh Sadeghi, Mahsa Shelerangkon, Mahnaz Hosseini Rizi, et al. (+3)
45 [GO] 2022―Sep―20 P494 Comparison of Candida colonization in intensive care unit patients with and without COVID-19: First prospective cohort study from Turkey İlvana Çaklovica Küçükkaya, Günseli Orhun, Arif Atahan Çağatay, Sadık Kalaycı, Figen Esen, Fikrettin Şahin, et al. (+2)
46 [GO] 2022―Sep―20 P168 Metastatic mo ld infections after COVID-19: the mo ld time -bomb Rajeev Soman, Sourabh Chakraborty, Geethu Joe, Bharat Purandare, Shweta Panchakshari, Sampada Patwardhan
47 [GO] 2022―Sep―20 P327 Prevalence of orofacial Mycoses in COVID-19patients: experience from a tertiary care center in Northern India Sonu Kumari Agrawal, Bansidar Tarai, Madhuri Somani
48 [GO] 2022―Sep―20 P193 Candidemia in coronavirus disease 2019 patients in a university hospital in Buenos Aires, Argentina Norma B. Fernandez, Luciana Farias, Stella Maris de Gregorio, Andrea Padovani, Monica Foccoli
49 [GO] 2022―Sep―20 S5.5d SARS-CoV-2 associated invasive fungal sinus infections; the Sri Lankan perspective H Thabrew, Liyanage Shamithra Madhumali Sigera, A P Anand, R A D M Ramanayake, Munasinghe M V, W L L N Wickramasekara, P I Jayasekera
50 [GO] 2022―Sep―20 P374 Fungal coinfection in patients with SARS-CoV-2: Atertiary care hospital study Vikas Saini, Gargi Rai, Praveen Singh, Shukla Das, Narendra Pal Singh
51 [GO] 2022―Sep―20 S1.4b Challenges in diagnosing and management of invasive fungal infections during the pandemic Methee Chayakulkeeree
52 [GO] 2022―Sep―20 P273 Diagnostic dilemmas in Pneumocystis pneumonia in case of long COVID -19 Arpit Shah
53 [GO] 2022―Aug―27 SARS-CoV-19-associated Rhino-orbital and cerebral Mucormycosis: Clinical and Radiological Presentations Ashima Mittal, Nitika Mahajan, Devinder Pal Singh Dhanota, Birinder S Paul, Srishti Ahluwalia, Saumya Ahluwalia, et al. (+11)
54 [GO] 2022―Jun―16 ‘Risk factors for COVID-19 associated mucormycosis in India: A case control study.’ Atul K Patel, Harsh Bakshi, Kahaan Shah, Saloni Patel, Tushar Patel, Kamlesh Patel, Ketan K Patel
55 [GO] 2022―Apr―08 Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina Gustavo Giusiano, Norma B Fernández, Roxana G Vitale, Christian Alvarez, María Eugenia Ochiuzzi, Gabriela Santiso, et al. (+7)
56 [GO] 2021―Nov―10 Clinical characteristics and risk factors for COVID-19-associated Candidemia Ali S Omrani, Junais Koleri, Fatma Ben Abid, Joanne Daghfal, Thasneem Odaippurath, Mohamed Zuhail Peediyakkal, et al. (+5)
 [1] 

56 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec